Oncogenomics is a sub-field of genomics that portrays malignant growth-related qualities. It centres on genomic, epigenetics and transcript changes in malignancy. Malignancy is a hereditary illness brought about by the gathering of DNA transformations and epigenetic modifications prompting unreasonable cell expansion and neoplasm arrangement. The objective of oncogenomics is to recognize new oncogenes or a tumour silencer quality that may give new bits of knowledge into malignant growth conclusion, foreseeing the clinical result of diseases and new focuses for disease treatments. The accomplishment of focused malignant growth treatments, for example, Gleevec, Herceptin and Avastin raised the expectation for oncogenomics to clarify new focuses for disease treatment


  • Cancer Genomics
  • Cancer Genome Sequencing
  • Cancer Epigenetics
  • Cancer Pharmacogenetics

Related Conference of Oncogenomics

June 28-30 2020

Stroke Summit 2020

June 15-16, 2020

24th Global Congress on Biotechnology

London, UK
July 15-16, 2020

12th World Congress and Expo on Stem Cell Research

Prague, Czech Republic
July 15-16, 2020

25th World Biotechnology Congress

London, UK
September 21-22, 2020

14th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Oncogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in